SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Bristol-Myers (BMY)

BMY RSS Feed
Add BMY Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board:
Last Post: 1/19/2017 7:56:05 PM - Followers: 28 - Board type: Free - Posts Today: 8
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMY
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BMY News: Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer 06:30 PM
BMY News: Opdivo (nivolumab) Demonstrated Efficacy & Improved Survival in Patients with Previously Treated Advanced Gastric Cancer in a... 09:00 AM
BMY News: Bristol-Myers Squibb and GeneCentric Diagnostics Announce Exploratory Biomarker Research Collaboration 01/06/2017 06:59:00 AM
BMY News: Bristol-Myers Squibb Announces Immunotherapy Clinical Collaboration with Janssen to Evaluate Opdivo (nivolumab) in Combinatio... 01/05/2017 06:59:00 AM
BMY News: Five Prime Therapeutics and Bristol-Myers Squibb Extend Research Term in Collaboration to Discover Novel Immuno-Oncology Ther... 01/04/2017 04:05:00 PM
News News Alert: Bristol-Myers Squibb Provides Regulatory Update in First-line Lung Cancer 01/19/2017 06:30:00 PM
PostSubject
#390  Sticky Note BMY -6%/AH on non-filing of Opdivo/Yervoy combo for DewDiligence 01/19/17 07:23:09 PM
#394   BMY PPS has dropped from high 70's to 2014shelby 01/19/17 07:56:05 PM
#393   BMY has a lot riding on the Opdivo/Yervoy DewDiligence 01/19/17 07:51:01 PM
#392   BMY PPS almost down to $40's. Not good 2014shelby 01/19/17 07:45:36 PM
#391   Opdivo approval for gastric cancer in Japan, Korea, DewDiligence 01/19/17 07:25:50 PM
#390   BMY -6%/AH on non-filing of Opdivo/Yervoy combo for DewDiligence 01/19/17 07:23:09 PM
#389   Bristol Myers Squibb : An Application for the chmcnfunds 01/19/17 02:29:18 PM
#387   Opdivo (nivolumab) Demonstrated Efficacy and Improved Survival in chmcnfunds 01/19/17 09:06:27 AM
#386   Why Bristol-Myers Squibb May Be a Merger Target Soon chmcnfunds 01/17/17 12:35:10 PM
#385   HEALTH NEWS / Wed Jan 11, 2017 / chmcnfunds 01/11/17 09:27:42 AM
#384   Transcript from JPMorgan: chmcnfunds 01/10/17 03:36:56 PM
#383   Now down on rumor of trial suspension: chmcnfunds 01/06/17 10:22:04 AM
#382   Not sure if rumor or they are creating chmcnfunds 01/05/17 10:41:34 AM
#381   Bristol-Myers Squibb Co (NYSE:BMY) Agrees To Extend Research trendmkr 01/05/17 10:39:42 AM
#380   Suppose the time of the information had something chmcnfunds 01/05/17 08:34:44 AM
#379   Most drug/biotech stocks were strong today, so there DewDiligence 01/04/17 04:08:17 PM
#378   From The Fly: chmcnfunds 01/04/17 03:25:05 PM
#377   Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for chmcnfunds 01/03/17 12:24:06 PM
#376   Bristol-Myers Is Poised To Break Out In 2017 chmcnfunds 12/27/16 10:07:25 AM
#375   Nice day $BMY 56.99 +1.76 (+3.19%) with a 1center 12/09/16 01:20:23 PM
#374   Any thoughts on how BMY will react due MrTrader129 12/08/16 11:38:26 PM
#373   BMY raises quarterly dividend by a penny: DewDiligence 12/08/16 07:48:33 PM
#372   Opdivo has eight FDA-approved indications: #msg-126508717. DewDiligence 11/12/16 12:05:58 PM
#371   BMY: north40000 11/11/16 11:08:33 AM
#370   FDA approves Opdivo monotherapy for second-line H&N cancer: DewDiligence 11/10/16 03:34:57 PM
#369   Bristol-Myers Squibb, Infinity Pharma Team Up On Opdivo trendmkr 11/10/16 12:04:41 PM
#368   You probably saw this: chmcnfunds 11/10/16 10:49:39 AM
#367   I'm somewhat surprised to see BMY committing serious DewDiligence 11/10/16 09:21:03 AM
#366   Bristol-Myers nabs global rights to liver fibrosis candidates, chmcnfunds 11/10/16 09:07:54 AM
#365   Bristol-Myers' Opdivo successful in late-stage gastric cancer study chmcnfunds 11/10/16 07:56:06 AM
#364   Was able to avg. down. Me green!! avg @55.08 1center 11/09/16 11:42:31 AM
#363   BMY not able to partner with Peregrine Pharmaceuticals biopharm 10/28/16 07:57:58 PM
#362   Yep. I thought the same thing ~ 5 2014shelby 10/27/16 06:07:57 PM
#361   It's not going back to the $70s in DewDiligence 10/27/16 04:25:35 PM
#360   Yep. Thanks. Not sure the buyback will be 2014shelby 10/27/16 03:48:08 PM
#359   Read today's PR ....you will know as much north40000 10/27/16 03:37:10 PM
#358   What are they gonna do to get the 2014shelby 10/27/16 03:32:06 PM
#357   BMY: CNBC interview,@1:40 pm, of CEO--IMO, generalities, nothing north40000 10/27/16 01:57:57 PM
#356   None what so ever. Let's revisit this next quarter. pennystockaholic 10/27/16 01:45:13 PM
#355   BMY +6% on Eliquis growth/buyback authorization—and AZN setback: DewDiligence 10/27/16 12:03:18 PM
#354   I dont know about the bristol-myers part,but it FAILURE TO DELIVER 10/10/16 11:47:28 PM
#353   BMY ESMO slides: DewDiligence 10/09/16 04:04:28 PM
#352   Not yet, AFAIK. We should be getting a DewDiligence 09/29/16 09:06:27 AM
#351   Have any been successful so far that you north40000 09/29/16 04:14:40 AM
#350   Thinking about starting a position around the $55 JTrader 09/28/16 09:31:38 PM
#349   How about getting back above $70? Or maybe 2014shelby 09/27/16 08:30:16 PM
#348   Tomorrow we close Green $$ MARINO 09/26/16 05:19:12 PM
#347   am surprised to see bmy still down here budmgd 09/26/16 04:43:08 PM
#346   Sept25-28 2016: “2nd CRI-AACR-CIMT-EATI Intl. Cancer Immunotherapy Conf.”, north40000 09/26/16 03:13:53 PM
#345   Yes, BMY is trying a wide array of DewDiligence 09/26/16 02:08:03 PM
#344   You are correct there too....MRK, AZN and Roche north40000 09/26/16 01:43:56 PM
PostSubject